DIA442.12+1.97 0.45%
SPX6,261.66+17.90 0.29%
IXIC20,725.55+47.75 0.23%

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket

Benzinga·06/18/2025 10:14:18
Listen to the news

Shares of Beyond Air, Inc. (NASDAQ:XAIR) fell sharply in today's pre-market trading after the company posted mixed fourth-quarter results.

Beyond Air reported quarterly losses of nine cents per share, which beat the analyst consensus estimate of a loss of 12 cents. Quarterly revenue came in at $1.15 million, which missed the Street estimate of $1.39 million and is up from revenue of $470,000 from the same period last year

Beyond Air shares dipped 23.5% to $0.2179 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • PTL Limited (NASDAQ:PTLE) surged 148% to $0.4923 in pre-market trading after gaining 10% on Tuesday.
  • XCF Global, Inc.  (NASDAQ:SAFX) shares jumped 67.6% to $2.85 in pre-market trading after dipping 23% on Tuesday.
  • Leishen Energy Holding Co., Ltd. (NASDAQ:LSE) jumped 53.5% to $8.52 in pre-market trading after tumbling 17% on Tuesday.
  • Gulf Resources, Inc. (NASDAQ:GURE) gained 44.2% to $0.8652 in pre-market trading after gaining 5% on Tuesday.
  • Mesa Royalty Trust (NYSE:MTR) rose 33.7% to $8.76 in pre-market trading after gaining 10% on Tuesday.
  • GeoVax Labs, Inc. (NASDAQ:GOVX) rose 30% to $1.17 in pre-market trading. GeoVax Labs shares dipped 32% on Tuesday after the company in a filing disclosed it will sell 6.15 million common units.
  • Helius Medical Technologies, Inc. (NASDAQ:HSDT) climbed 26.9% to $0.3921 in pre-market trading after dipping 18% on Tuesday.
  • TMC the metals company Inc. (NASDAQ:TMC) surged 11.8% to $6.07 in pre-market trading. Korea Zinc recently announced an equity investment of $85.2 million in the company.
  • Liminatus Pharma, Inc. (NASDAQ:LIMN) gained 7.7% to $13.82 in pre-market trading after surging over 5% on Tuesday.
  • BiomX Inc. (NYSE:PHGE) fell 7.7% to $0.4200 in pre-market trading.

Losers

  • Catalyst Biosciences, Inc. (NASDAQ:CBIO) shares tumbled 59.4% to $5.39 in pre-market trading. Crescent Biopharma recently completed closing of merger with GlycoMimetics and previously announced private placement of $200 million.
  • Biomea Fusion, Inc. (NASDAQ:BMEA) shares fell 26.2% to $2.14 in pre-market trading after the company announced the pricing of public offering of securities.
  • BP Prudhoe Bay Royalty Trust (NYSE:BPT) dipped 24.2% to $0.54 in pre-market trading. BP Prudhoe Bay Royalty Trust announced commencement of trust asset sale process.
  • Eyenovia, Inc. (NASDAQ:EYEN) declined 22.4% to $5.41 in pre-market trading. Eyenovia shares jumped 135% on Tuesday after the company announced it entered into a securities purchase agreement for a $50 million private placement in public equity with institutional accredited investors.
  • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) dipped 22.4% to $15.35 in pre-market trading. CERo Therapeutics shares jumped 189% on Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236.
  • Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) declined 21% to $0.6485 in pre-market trading after the company announced exercise of warrants for $2.67 million gross proceeds.
  • LeddarTech Holdings Inc. (NASDAQ:LDTC) fell 14.4% to $0.1624 in pre-market trading. LeddarTech recently announced intention to file under the Bankruptcy and Insolvency Act in Canada.
  • Regencell Bioscience Holdings Limited (NASDAQ:RGC) fell 14.1% to $66.98 in pre-market trading after gaining 30% on Tuesday.
  • Vince Holding Corp. (NYSE:VNCE) fell 13.4% to $1.28 in pre-market trading after dipping 12% on Tuesday. Vince Holding recently posted a first-quarter loss of 37 cents per share.

Now Read This:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.